Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intuba...
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide or vecuronium bromide in adults and pediatric patients ≥2 years old who are undergoing surgery.
Stony Brook University Hospital, Stony Brook, New York, United States
Dept. of Anesthesiology and Intensive Care Medicine, University Hospital Olomouc, Olomouc, Czechia
Faculty of Medicine, Ain Shams University, Cairo, Egypt
AZ Maria Middelares, Gent, Oost-Vlaanderen, Belgium
Cleveland Clinic, Cleveland, Ohio, United States
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Virtua Memorial Hospital, Mount Holly, New Jersey, United States
Loyola University Medical Center, Maywood, Illinois, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.